Insulin efsitora alfa in type 2 diabetes: The evolution of basal insulin from daily to once-weekly formulations
Chair: Chantal Mathieu (BEL) 17:45 – 17:50 Welcome and introduction Chantal Mathieu (BEL) 17:50 – 18:00 From guideline recommendations to clinical reality: Barriers to achieving